Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00586339
What this trial is testing

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT03110770
What this trial is testing

VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents

Who this might be right for
Zika VirusZika Virus InfectionVirus Diseases+4 more
National Institute of Allergy and Infectious Diseases (NIAID) 2,428
Early research (Phase 1)Study completedNCT05408312
What this trial is testing

Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above

Who this might be right for
COVID-19 Pneumonia
National Vaccine and Serum Institute, China 234
Early research (Phase 1)Study completedNCT01585181
What this trial is testing

Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200

Who this might be right for
Cholera
Bavarian Nordic 66
Testing effectiveness (Phase 2)Study completedNCT02529930
What this trial is testing

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Who this might be right for
High Grade Cervical Intraepithelial Neoplasia
Nykode Therapeutics ASA 34
Large-scale testing (Phase 3)Not Yet RecruitingNCT07028801
What this trial is testing

Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)

Who this might be right for
Rabies
Ningbo Rongan Biological Pharmaceutical Co., Ltd. 3,000
Early research (Phase 1)Study completedNCT04830800
What this trial is testing

A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)

Who this might be right for
COVID-19 DiseaseSARS PneumoniaPneumonia, Viral+1 more
Institute of Vaccines and Medical Biologicals, Vietnam 120
Large-scale testing (Phase 3)Study completedNCT00489554
What this trial is testing

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
GlaxoSmithKline 230
Testing effectiveness (Phase 2)Study completedNCT01052402
What this trial is testing

Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents

Who this might be right for
Influenza, Avian
Alachua Government Services, Inc. 684
Early research (Phase 1)Study completedNCT00104845
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 19
Not applicableStudy completedNCT03383653
What this trial is testing

Safety Profile Following Td Vaccination in Indonesian Pregnant Woman

Who this might be right for
HealthyPregnant
PT Bio Farma 200
Post-approval studies (Phase 4)Study completedNCT00735475
What this trial is testing

Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

Who this might be right for
Influenza
Seqirus 1,268
Large-scale testing (Phase 3)Study completedNCT03964012
What this trial is testing

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Who this might be right for
Meningococcal Meningitis
Serum Institute of India Pvt. Ltd. 1,800
Large-scale testing (Phase 3)Study completedNCT05317767
What this trial is testing

The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.

Who this might be right for
Influenza
St. Petersburg Research Institute of Vaccines and Sera 600
Testing effectiveness (Phase 2)UnknownNCT01189656
What this trial is testing

A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B Patients With HBeAg-positive
The 458 Hospital of Chinese PLA 33
Large-scale testing (Phase 3)Study completedNCT00929331
What this trial is testing

Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years

Who this might be right for
Influenza, Human
GlaxoSmithKline 110
Not applicableStudy completedNCT01007201
What this trial is testing

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population

Who this might be right for
Influenza
Adimmune Corporation 183
Large-scale testing (Phase 3)Study completedNCT05836012
What this trial is testing

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

Who this might be right for
Gastroenteritis
HilleVax 329
Not applicableStudy completedNCT01983553
What this trial is testing

Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 3,203
Early research (Phase 1)Study completedNCT00001037
What this trial is testing

A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 22
Next Page